KevinMD February 25, 2024
Scott Janssen, MSW, LCSW

I’m sitting in a windowless room in the hospital’s urology department waiting for my second prostate biopsy, feeling surprisingly calm and relaxed.

It’s a surveillance biopsy. Two years ago, the first one revealed “a few scattered cancer cells” while zeroing in on what turned out to be a harmless nodule. I’d learned then that a prostate biopsy will never make anyone’s list of fun things to do. In addition to being, eh, awkward, it was painful and invasive.

Prior to the first one, I’d been anxious, my imagination spinning worst-case scenarios of being whisked to the oncology department to schedule radiation. This time, I know we’ve caught it early and my PSA has consistently been inside the normal range at...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Patient / Consumer, Provider
50 things to know about HCA, Tenet, CHS and UHS
How Mercy accelerated rare disease diagnoses in rural areas
Private equity-backed radiology provider Solis Mammography inks joint venture deal with large hospital system
Why health system AI predictions can fail
HCA Midwest opens $9.3M Missouri ASC

Share This Article